the combination of ifosfamide , etoposide and methotrexate was evaluated in 22 patients with non-hodgkin 's lymphoma ( nhl ) whose disease had relapsed or was resistant to first-line adriamycin-containing treatment .
C0020823
ifosfamide
C0024305
non-hodgkin 's lymphoma